Comparison of the Effect of Intra Articular Steroid Injection and Pericapsular Nerve Group Block for Hip Osteoarthritis

Overview

The most common cause of hip joint dysfunction in the elderly is degenerative osteoarthritis of the hip. Innervation of the hip joint capsule is provided by the obturator nerve, the accessory obturator nerve, and the femoral nerve. With pericapsular nerve group block (PENG), by blocking the femoral nerve and the accessory obturator nerve, analgesia is successfully provided for the hip joint. Intra-articular injection of corticosteroids; It is used as an alternative to surgical interventions because it reduces inflammation and short-term pain and is a minimally invasive method. The investigators aim to compare and report patients who underwent ultrasound-guided intra-articular steroid injection and PENG block in terms of post-procedural pain scores and patient satisfaction.

Full Title of Study: “Comparison of Ultrasound Guided Intra-articular Steroid Injection and Pericapsular Nerve Group Block (PENG) in Patients With Chronic Hip Pain”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Triple (Participant, Care Provider, Outcomes Assessor)
  • Study Primary Completion Date: August 20, 2021

Interventions

  • Procedure: intraarticular injection
    • Ultrasound-guided intraarticular injection
  • Procedure: peng block
    • Ultrasound-guided PENG block

Arms, Groups and Cohorts

  • Experimental: intraarticular injection
    • intra-articular steroid injection with the ultrasound guidance technique,
  • Active Comparator: peng block
    • Ultrasound guided drug injection between to iliopubic eminentia and psoas tendon

Clinical Trial Outcome Measures

Primary Measures

  • numerical rating scale (NRS) pain score
    • Time Frame: change from baseline to day 1, week 2, 4, 8 after the block
    • The 11-point NRS consists of numbers between 0 and 10 where 0 indicates “no pain” and 10 indicates “maximum pain.” The patient is instructed to identify one number between 0 and 10, which is best representative of their pain intensity.

Secondary Measures

  • Quality of Life (WOMAC)
    • Time Frame: baseline to 8 weeks
    • The Western Ontario and McMaster Universities (WOMAC) is a self-administered health status measure and consists of 24 items divided into three domains, which are pain, stiffness, and physical function, validated to patients with hip or knee osteoarthritis

Participating in This Clinical Trial

Inclusion Criteria

  • Hip pain NRS > 4 – No pathologies in the laboratory and coagulation parameters Exclusion Criteria:

  • Rheumatological disease with hip involvement – Systemic active infection – Malignancy – History of hip joint surgery – History of traumatic hip injury – Platelets values < 150.000 / µl – History of bleeding disorder

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Diskapi Teaching and Research Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Selin Guven Kose, principal Investigator – Diskapi Teaching and Research Hospital
  • Overall Official(s)
    • selin guven kose, Principal Investigator, Diskapi Teaching and Research Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.